In trading on Friday, shares of the Direxion Daily S&P Biotech Bear 3x Shares ETF (LABD) fell to $8.06 per share, entering oversold territory with a Relative Strength Index (RSI) of 29.5. Stocks are considered oversold when the RSI dips below 30; for comparison, the S&P 500’s RSI stands at 45.1.
Over the past year, LABD has experienced a 52-week range with a low of $8.06 and a high of $76.95, last trading at $8.15—a decline of approximately 3.2% on the day. This RSI reading may signal to bullish investors that recent heavy selling could be nearing exhaustion, presenting potential buy opportunities.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
